Group One Trading’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-14,600
| Closed | -$66.1K | – | 8007 |
|
|
2025
Q3 | $66.1K | Buy |
14,600
+13,400
| +1,117% | +$39.5K | ﹤0.01% | 5729 |
|
|
2025
Q2 | $2.58K | Buy |
1,200
+800
| +200% | +$2.24K | ﹤0.01% | 7336 |
|
|
2025
Q1 | $1.75K | Buy |
+400
| New | +$1.8K | ﹤0.01% | 7038 |
|
|
2024
Q4 | – | Sell |
-8,800
| Closed | -$61.8K | – | 7190 |
|
|
2024
Q3 | $61.8K | Buy |
8,800
+8,400
| +2,100% | +$61K | ﹤0.01% | 4507 |
|
|
2024
Q2 | $2.74K | Buy |
400
+300
| +300% | +$2.79K | ﹤0.01% | 6141 |
|
|
2024
Q1 | $1.41K | Buy |
+100
| New | +$1.52K | ﹤0.01% | 6562 |
|
|
2023
Q4 | – | Sell |
-12,160
| Closed | -$182K | – | 7294 |
|
|
2023
Q3 | $182K | Buy |
12,160
+12,130
| +40,433% | +$218K | ﹤0.01% | 3886 |
|
|
2023
Q2 | $477 | Buy |
+30
| New | +$315 | ﹤0.01% | 7376 |
|
|
2023
Q1 | – | Sell |
-66,690
| Closed | -$386K | – | 7127 |
|
|
2022
Q4 | $386K | Sell |
66,690
-10,290
| -13% | -$78K | ﹤0.01% | 3278 |
|
|
2022
Q3 | $731K | Sell |
76,980
-7,120
| -8% | -$93.6K | ﹤0.01% | 2878 |
|
|
2022
Q2 | $1.01M | Sell |
84,100
-5,290
| -6% | -$55.4K | ﹤0.01% | 2748 |
|
|
2022
Q1 | $1.17M | Sell |
89,390
-54,050
| -38% | -$791K | ﹤0.01% | 2931 |
|
|
2021
Q4 | $2.52M | Buy |
143,440
+11,780
| +9% | +$236K | ﹤0.01% | 2337 |
|
|
2021
Q3 | $2.86M | Buy |
131,660
+110,280
| +516% | +$2.81M | ﹤0.01% | 2292 |
|
|
2021
Q2 | $748K | Buy |
21,380
+19,130
| +850% | +$1.03M | ﹤0.01% | 3746 |
|
|
2021
Q1 | $222K | Sell |
2,250
-2,450
| -52% | -$294K | ﹤0.01% | 4915 |
|
|
2020
Q4 | $509K | Buy |
4,700
+3,260
| +226% | +$403K | ﹤0.01% | 3245 |
|
|
2020
Q3 | $148K | Sell |
1,440
-430
| -23% | -$64.4K | ﹤0.01% | 3886 |
|
|
2020
Q2 | $390K | Buy |
1,870
+570
| +44% | +$101K | ﹤0.01% | 2839 |
|
|
2020
Q1 | $127K | Sell |
1,300
-890
| -41% | -$104K | ﹤0.01% | 3105 |
|
|
2019
Q4 | $252K | Sell |
2,190
-3,470
| -61% | -$306K | ﹤0.01% | 2999 |
|
|
2019
Q3 | $308K | Buy |
5,660
+5,590
| +7,986% | +$630K | ﹤0.01% | 2748 |
|
|
2019
Q2 | $8K | Sell |
70
-3,490
| -98% | -$289K | ﹤0.01% | 4478 |
|
|
2019
Q1 | $187K | Buy |
3,560
+1,560
| +78% | +$63.1K | ﹤0.01% | 2753 |
|
|
2018
Q4 | $63K | Sell |
2,000
-5,890
| -75% | -$240K | ﹤0.01% | 3421 |
|
|
2018
Q3 | $477K | Buy |
7,890
+490
| +7% | +$27.5K | ﹤0.01% | 2334 |
|
|
2018
Q2 | $392K | Sell |
7,400
-5,740
| -44% | -$345K | ﹤0.01% | 2502 |
|
|
2018
Q1 | $762K | Buy |
+13,140
| New | +$818K | 0.01% | 1716 |
|
|
2016
Q2 | – | Sell |
-2,520
| Closed | -$130K | – | 4577 |
|
|
2016
Q1 | $130K | Sell |
2,520
-690
| -21% | -$38.5K | ﹤0.01% | 2639 |
|
|
2015
Q4 | $306K | Sell |
3,210
-3,340
| -51% | -$293K | ﹤0.01% | 2186 |
|
|
2015
Q3 | $540K | Sell |
6,550
-1,010
| -13% | -$129K | 0.01% | 1717 |
|
|
2015
Q2 | $1.23M | Buy |
7,560
+7,200
| +2,000% | +$2.43M | 0.02% | 1063 |
|
|
2015
Q1 | $146K | Buy |
+360
| New | +$152K | ﹤0.01% | 2623 |
|
Group One Trading's ADVM Position: Q2 2025 in Review
Group One Trading sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 292 shares — an estimated $817 sold.
Group One Trading first reported a position in ADVM in Q1 2015 and held it in 25 quarters. The position peaked at $2.34M in Q2 2015. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.
- Group One Trading reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 292 Adverum Biotechnologies shares in Q2 2025, an estimated $817.
- Group One Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 25 quarters.
- Group One Trading's Adverum Biotechnologies position peaked at $2.34M in Q2 2015.
- 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.